TNFRSF4 and lung adenocarcinoma: Our group previously showed that a single cycle of SBRT (12Gy×3 fractions) combined with a costimulatory OX40 agonist produced abscopal responses in a murine model of PD1-resistant lung adenocarcinoma while RT or OX40 agonist alone did not (23).